Concepedia

Catherine L. Tan

CL

5

Publications

571

Citations

5

H-Index

2009

Active since

Affiliations

Dana-Farber Cancer Institute(Current)

Brigham and Women's Hospital

Harvard University

University of California, San Francisco

Catherine L. Tan is an author at Dana-Farber Cancer Institute specializing in autoimmunity, autoimmune disease, and humoral immunity.

ORCID

Top concepts

Publications per year

2009–2020

5

Publications

5

PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance

Catherine L. Tan, Juhi R. Kuchroo, Peter T. Sage et al. · The Journal of Experimental Medicine · 2020 · 246 citations · Full text

Defective TFH Cell Function and Increased TFR Cells Contribute to Defective Antibody Production in Aging

Peter T. Sage, Catherine L. Tan, Gordon J. Freeman et al. · Cell Reports · 2015 · 128 citations · Full text

, , +15

BPIFB1 Is a Lung-Specific Autoantigen Associated with Interstitial Lung Disease

Anthony K. Shum, Mohammad Alimohammadi, Catherine L. Tan et al. · Science Translational Medicine · 2013 · 96 citations · Full text

Identification of an Autoantigen Demonstrates a Link Between Interstitial Lung Disease and a Defect in Central Tolerance

Anthony K. Shum, Jason DeVoss, Catherine L. Tan et al. · Science Translational Medicine · 2009 · 68 citations · Full text

CD160 Stimulates CD8+ T Cell Responses and Is Required for Optimal Protective Immunity to <i>Listeria monocytogenes</i>

Catherine L. Tan, Michael J. Peluso, Jefte M. Drijvers et al. · ImmunoHorizons · 2018 · 33 citations · Full text

Rows per page

1–5 of 5